Pill Identifier App

WPI 867 (Bupropion Extended-Release (SR) 150 mg)

Pill imprint WPI 867 has been identified as Bupropion hydrochloride extended-release (SR) 150 mg.

Bupropion is used in the treatment of sexual dysfunction, ssri induced; major depressive disorder; depression; adhd; anxiety (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 867

Bupropion hydrochloride extended-release (SR) 150 mg WPI 867  Front
Bupropion hydrochloride extended-release (SR) 150 mg WPI 867  Back
Bupropion hydrochloride extended-release (SR) 150 mg WPI 867
Bupropion hydrochloride extended-release (SR) 150 mg WPI 867
Bupropion hydrochloride extended-release (SR)
Imprint:
WPI 867
Strength:
150 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antidepressants
Smoking cessation agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0867

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)